Somewhat less encouraging results were obtained in patients with relapsed SCLC [127] where only 2.6 % of patients showed a partial response (although drug-induced apoptosis was more pronounced in patients thought to express BCL-2 more highly). The gene discussed is BCL2; the disease is small cell lung carcinoma.